MediConnect, the developer of a framework blockchain solution to trace and manage prescription medication, today announced that it has completed the workflow for the Proof-of-Concept (PoC) and has begun the integration of UK Meds, an online pharmacy to the MediConnect PoC platform.
The completed workflow is a significant step forth for MediConnect that establishes a foundation on which to finalize the PoC, which is designed to track medication through the supply chain from the point at which it is manufactured to its prescription by medical professionals and purchase by patients.
Following the completion of the PoC workflow, MediConnect has commenced the integration of UK Meds to its PoC platform.
Pilot 2020
The experience and knowledge gained during the workflow process will prove invaluable as MediConnect progresses towards completion of the PoC and a pilot scheme with up to 10 online pharmacies, including UK Meds, in 2020.
UK Meds is one of the largest and fastest-growing online pharmacies in the UK with a user-base of approximately 400,000 people, issuing 1,000s of prescriptions on the UK Meds website every day.
The current processes of UK Meds will be integrated into the MediConnect solution in one cohesive platform to trace products through its supply chain and prevent the misuse of prescription drugs.
The MediConnect blockchain is being developed by Stratis Group Ltd as a bespoke solution based on the Stratis blockchain. MediConnect has launched its own MEDI token to handle transactions and transfer value on its platform.
“We are delighted to have completed the workflow for the proof-of-concept, an important milestone in MediConnect’s development. The next step is to complete the integration of UK Meds to our proof-of-concept platform and complete a pilot scheme in 2020. The pilot scheme will include up to 10 online pharmacies and bring to life our goal of solving the growing issue of overuse of prescription medication, which will help protect the health of patients while reducing costs for the NHS.”
– Dexter Blackstock, CEO of MediConnect
